Chinese General Practice ›› 2018, Vol. 21 ›› Issue (36): 4429-4433.DOI: 10.12114/j.issn.1007-9572.2018.00.217
• Monographic Research • Previous Articles Next Articles
Published:
2018-12-20
Online:
2018-12-20
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2018.00.217
[1]ABALOVICH M,AMINO N,BARBOUR L A,et al.Management of thyroid dysfunction during pregnancy and postpartum:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2007,92(8 Suppl):S1-47.DOI:10.1210/jc.2007-0141. [2]MOLETI M,TRIMARCHI F,VERMIGLIO F.Thyroid physiology in pregnancy[J].Endocr Pract,2014,20(6):589-596.DOI:10.4158/EP13341.RA. [3]叶元华,李静,詹瑛,等.脂肪和胎盘组肿瘤坏死因子-α表达与妊娠期糖尿病胰岛素抵抗的相关性研究[J].中华围产医学杂志,2007,10(1):24-28.DOI:10.3760/cma.j.issn.1007-9408.2007.01.007. [4]GAO X L,YANG H X,ZHAO Y.Variations of tumor necrosis factor-α,leptin and adiponectin in mid-trimester of gestational diabetes mellitus[J].Chin Med J(Engl),2008,121(8):701-705. [5]谢洪.瘦素水平对于预测妊娠期糖尿病的临床价值研究[J].中国妇幼卫生杂志,2016,7(1):30-33. [6]BITTERMAN O,BONGIOVANNI M,GIULIANI C,et al.Anti thyroperoxidase and anti thyroglobulin antibodies in diabetic pregnancies[J].J Endocrinol Invest,2014,37(10):911-915.DOI:10.1007/s40618-014-0087-4. [7] PHILIPS J C,EMONTS P,PINTIAUX A,et al.Management of gestational diabetes[J].Rev Med Liege,2013,68(9):489-496. [8]SCHNEIDER S,BOCK C,WETZEL M,et al.The prevalence of gestational diabetes in advanced economies[J].J Perinat Med,2012,40(5):511-520.DOI:10.1515/jpm-2012-0015. [9]TUTINO G E,TAM W H,YANG X,et al.Diabetes and pregnancy:perspectives from Asia[J].Diabet Med,2014,31(3):302-318.DOI:10.1111/dme.12396. [10]KIM C,NEWTON K M,KNOPP R H.Gestational diabetes and the incidence of type 2 diabetes:a systematic review[J].Diabetes Care,2002,25(10):1862-1868. [11]BELLAMY L,CASAS J P,HINGORANI A D.Type 2 diabetes mellitus after gestational diabetes:a systematic review and meta-analysis[J].Lancet,2009,373(9677):1773-1779.DOI:10.1016/S0140-6736(09)60731-5. [12]NERENBERG K,DASKALOPOULOU S S,DASGUPTA K.Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals:an overview and grading of the evidence[J].Can J Cardiology,2014,30(7):765-773.DOI:10.1016/j.cjca.2013.12.030. [13]张娅,徐先明.妊娠期糖尿病病因学研究进展[J].中国实用妇科与产科杂志,2013,29(4):299-302. [14]中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南[J].中华内分泌代谢杂志,2012,28(5):354-371. [15]GUDOVIC A,SPREMOVIC-RADJENOVIC S,LAZOVIC G,et al.Maternal autoimmune thyroid disease and pregnancy complication[J].Vojnosanit Pregl,2010,67(8):617-621. [16]王巧敏,刘怀昌,李蕊,等.甲状腺功能减退对妊娠期糖尿病孕妇糖代谢及胰岛素敏感性的影响[J].广东医学,2016,37 (2):245-246.DOI:10.13820/j.cnki.gdyx.2016.02.020. [17]吉卉.甲状腺功能减退对妊娠期糖尿病影响的研究[D].天津:天津医科大学,2013. [18]MAO H,LI Q,GAO S.Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus[J].PLoS One,2012,7(9):e45882.DOI:10.1371/journal.pone.0045882. [19] ZHANG C,BAO W,RONG Y,et al.Genetic variants and the risk of gestational diabetes mellitus:a systematic review[J].Hum Reprod Update,2013,19(4):376-390.DOI:10.1093/humupd/dmt013. [20]MORRIS A P,VOIGHT B F,TESLOVICH T M,et al.Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes[J].Nat Genet,2012,44(9):981-990.DOI:10.1038/ng.2383. [21]BASILE K J,JOHNSON M E,XIA Q,et al.Genetic susceptibility to type 2 diabetes and obesity:follow-up of findings from genome-wide association studies[J].Int J Endocrinol,2014:769671.DOI:10.1155/2014/769671. [22]MOHLKE K L,BOEHNKE M.Recent advances in understanding the genetic architecture of type 2 diabetes[J].Hum Mol Genet,2015,24(1):R85-92.DOI:10.1093/hmg/ddv264. [23]MULDER H,NAGORNY C L,LYSSENKO V,et al.Melatonin receptors in pancreatic islets:good morning to a novel type 2 diabetes gene[J].Diabetologia,2009,52(7):1240-1249.DOI:10.1007/s00125-009-1359-y. [24]PESCHKE E,MUEHLBAUER E.New evidence for a role of melatonin in glucose regulation[J].Best Pract Res Clin Endocrinol Metab,2010,24(5):829-841.DOI:10.1016/j.beem. [25]STANCAKOVA A,KUULASMAA T,PAANANEN J,et al.Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release,proinsulin conversion,and insulin sensitivity in 5,327 nondiabetic Finnish men[J].Diabetes,2009,58(9):2129-2136.DOI:10.2337/db09-0117. [26]GROENEWOUD M J,DEKKER J M,FRITSCHE A,et al.Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps[J].Diabetologia,2008,51(9):1659-1663.DOI:10.1007/s00125-008-1083-z. [27] IRWIN D M,TAN H.Evolution of glucose utilization:glucokinase and glucokinase regulator protein[J].Mol Phylogenet Evol,2014,70:195-203.DOI:10.1016/j.ympev.2013.09.016. [28]ULLRICH S,SU J,RANTA F,et al.Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells[J].Pflugers Arch,2005,451(3):428-436.DOI:10.1007/s00424-005-1479-2. [29]DIMAS A S,LAGOU V,BARKER A,et al.Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity[J].Diabetes,2014,63(6):2158-2171.DOI:10.2337/db13-0949. [30]LIN J D,YANG S F,WANG Y H,et al.Associations of melatonin receptor gene polymorphisms with Graves' disease[J].PLoS One,2017,12(9):e0185529.DOI:10.1371/journal.pone.0185529. [31] R?NN T,WEN J,YANG Z,et al.A common variant in MTNR1B,encoding melatonin receptor 1B,is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals[J].Diabetologia,2009,52(5):830-833.DOI:10.1007/s00125-009-1297-8. [32] NAKAMURA E,KOZAKI K,TSUDA H,et al.Frequent silencing of putative tumor suppressor gene melatonin receptor 1 A(MTNR1A) in oral squamous-cell carcinoma[J].Cancer Sci,2008,99(7):1390-1400.DOI:10.1111/j.1349-7006.2008.00838.x. [33]LI C,QIAO B,ZHAN Y,et al.Association between genetic variations in MTNR1A and MTNR1B genes and gestational diabetes mellitus in Han Chinese women[J].Gynecol Obstet Invest,2013,76(4):221-227.DOI:10.1159/000355521. [34]JEON E J,HONG S Y,LEE J H.Adipokines and insulin resistance according to characteristics of pregnant women with gestational diabetes mellitus[J].Diabetes Metab J,2017,41(6):457-465.DOI:10.4093/dmj.2017.41.6.457. [35]赖丽萍,陆泽元,李翠吟,等.孕晚期妊娠期糖尿病脂联素、瘦素与胰岛素抵抗的相关性[J].实用预防医学,2012,19(8):1135-1137. [36]ORTEGA-SENOVILLA H,SCHAEFER-GRAF U,MEITZNER K,et al.Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood[J].Diabetes Care,2011,34(9):2061-2066.DOI:10.2337/dc11-0715. [37]LAMBADIARI V,MITROU P,MARATOU E,et al.Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes[J].Endocrine,2011,39(1):28-32.DOI:10.1007/s12020-010-9408-3. [38]PRATS-PUIG A,SITJAR C,RIBOT R,et al.Relative hypoadiponectinemia,insulin resistance,and increased visceral fat in euthyroid prepubertal girls with low-normal serum free thyroxine[J].Obesity,2012,20(7):1455-1461.DOI:10.1038/oby.2011.206. [39]白宇,赖亚新,李静,等.PTU诱导大鼠低甲状腺素血症与胰岛素抵抗相关[J].中国医科大学学报,2015,44(1):27-29,33. [40]MUELLER A,SCHOFL C,DITTRICH R,et al.Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome[J].Hum Reprod,2009,24(11):2924-2930.DOI:10.1093/humrep/dep285. [41]QIU C,SORENSEN T K,LUTHY D A,et al.A prospective study of maternal serum C-reactive protein(CRP) concentrations and risk of gestational diabetes mellitus[J].Paediatr Perinat Epidemiol,2004,18(5):377-384.DOI:10.1111/j.1365-3016.2004.00578.x. [42]赖亚新,王浩宇,范晨玲,等.促甲状腺激素对大鼠脂肪组织中瘦素,脂联素,TNF-α 及 IL-6 表达水平的影响[J].山东医药,2015,55(13):1-3.DOI:10.3969/j.issn.1002-266X.2015.13.001. [43] 卢敏,王英,陈青,等.炎性及脂肪细胞因子与妊娠期糖尿病发病的相关性及在产褥期的变化[J].中国妇幼保健,2012,47(6):436-439. [44] OH E S,HAN J H,HAN S M,et al.Adipokine concentrations in pregnant Korean women with normal glucose tolerance and gestational diabetes mellitus[J].Korean Diabetes J,2009,33(4):279-288.DOI :10.4093/kdj.2009.33.4.279. [45]于健,王炎,马金秀,等.妊娠期糖尿病患者血清瘦素水平与胰岛素抵抗的关系[J].中华糖尿病杂志,2005,13(3):172-173. [46]丰雪,樊淑华,于学静,等.甲状腺功能减退症患者血清内脂素和瘦素水平及意义[J].黑龙江医药科学,2016,39(1):87-91. [47] 林清兰,林晓岚,麦尚敏.妊娠期糖尿病孕妇甲状腺功能及甲状腺自身抗体的变化[J].广东医学,2014,35(9):1355-1356.DOI:10.13820/j.cnki.gdyx.2014.09.023. [48]PASCUAL C E,ANDRADA P.Is autoimmune thyroid dysfunction a risk factor for gestational diabetes? [J].Endocrinol Nutr,2014,61(7):377-381.DOI:10.1016/j.endonu.2014.01.009. [49] CHEN L M,ZHANG Q,SI G X,et al.Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women[J].Endocrine,2015,48(3):924-928.DOI:10.1007/s12020-014-0420-x. [50] 赵瑛,刘小庆,苏阳,等.妊娠糖尿病和糖尿病合并妊娠患者的甲状腺功能与抗体的变化分析[J].中国地方病防治杂志,2013,28(3):232-233. [51] NEGRO R,SCHWARTZ A,GISMONDI R,et al.Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes[J].J Clin Endocrinol Metab,2011,96(6):E920-924.DOI:10.1210/jc.2011-0026. [52] TOULIS K A,STAGNARO-GREEN A,NEGRO R.Maternal subclinical hypothyroidsm and gestational diabetes mellitus:a meta-analysis[J].Endocr Pract,2014,20(7):703-714.DOI:10.4158/EP13440.RA. [53] KARAKOSTA P,ALEGAKIS D,GEORGIOU V A,et al.Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes[J].J Clin Endocrinol Metab,2012,97(12):4464-4472.DOI:10.1210/jc.2012-2540. [54] 史晓光,韩成,李晨嫣,等.妊娠早期妇女甲状腺自身抗体分析[J].中华内分泌代谢杂志,2016,32(5):376-379.DOI:10.3760/cma.j.issn.1000-6699.2016.05.005. [55] YANG S,SHI F T,LEUNG P C,et al.Low thyroid hormone in early pregnancy is associated with an increased risk of gestational diabetes mellitus[J].J Clin Endocrinol Metab,2016,101(11):4237-4243.DOI:10.1210/jc.2016-1506. [56] OLIVIERI A,VALENSISE H,MAGNANI F,et al.High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus[J].Eur J Endocrinol,2000,143(6):741-747. [57] GONG L L,LIU H,LIU L H.Relationship between hypothyroidism and the incidence of gestational diabetes:a meta-analysis[J].Taiwan J Obstet Gynecol,2016,55(2):171-175.DOI:10.1016/j.tjog.2016.02.004. [58] REZZONICO J,NIEPOMNISZCZE H,REZZONICO M,et al.The association of insulin resistance with subclinical thyrotoxicosis[J].Thyroid,2011,21(9):945-949.DOI:10.1089/thy.2010.0402. [59]康苏娅,汪云,伍理.妊娠期糖尿病孕妇甲状腺功能及妊娠结局的研究[J].现代妇产科进展,2014,23(1):50-52.DOI:10.13283/j.cnki.xdfckjz.2014.01.039. [60]朱雨霏,赖亚新,姜凤伟,等.亚临床甲状腺功能减退症患者及甲状腺功能正常者甲状腺功能与血糖水平的关系[J].中华糖尿病杂志,2012,4(3):139-143.DOI:10.3760/cma.j.issn.1674-5809.2012.03.004. [61]李天惠.妊娠期亚临床甲状腺功能减退患者血糖代谢的变化分析[J].临床医学研究与实践,2016,1(14):122-123.DOI:10.19347/j.cnki.2096-1413.2016.14.091. |
[1] | YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314. |
[2] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[3] | LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307. |
[4] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[5] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[6] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
[7] | ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649. |
[8] | ZHAO Xiaohua, DU Lin, GAO Shengnan, JIANG Ziyun. Multiple Deep Muscle Abscesses in Type 2 Diabetes in the Elderly: Report of One Case and Literature Review [J]. Chinese General Practice, 2023, 26(29): 3715-3718. |
[9] | CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488. |
[10] | LUO Dan, XU Jingjing, WANG Yubing, LI Mingzi, FORBES Angus. Development and Preliminary Practice of Resilience-oriented Structured Treatment and Educational Program for Adolescents with Type 1 Diabetes [J]. Chinese General Practice, 2023, 26(27): 3423-3429. |
[11] | DONG Yanan, JIANG Xiaorui, WANG Kai, ZONG Chuanchong, LIN Guodong, LI Xiangqing, LIN Chunxiao, CHI Juntao. The Effect of Modified Tibial Transverse Transport Technique in the Treatment of Wagner Grade Ⅲ and Ⅳ Diabetic Foot Patients [J]. Chinese General Practice, 2023, 26(27): 3411-3416. |
[12] | CHEN Lunwen, ZHOU Yang, YAN Guodong, SHEN Yi, SUN Chen, CAI Wanli, CHU Minjie, XIAO Jing. Risk of Malignant Tumor in Patients with Type 2 Diabetes: a Prospective Population-based Study [J]. Chinese General Practice, 2023, 26(26): 3238-3245. |
[13] | FEI Sijie, ZHANG Qiang, LIU Fangfang, BAI Lu, SUN Caihong, XIN Caifeng. Correlation between Glycated Hemoglobin Variability and New-onset Atrial Fibrillation in Type 2 Diabetes Patients Combined with Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2023, 26(26): 3246-3251. |
[14] | GU Yunjie, SONG Jing, YIN Jun. Clinical Study on Low-carbon Diet for Endogenous-insulin-deficient Diabetes Patients [J]. Chinese General Practice, 2023, 26(26): 3308-3313. |
[15] | KONG Dexian, XING Yuling, SUN Wenwen, ZHANG Zhimin, ZHOU Fei, MA Huijuan. Correlation between Estimated Glucose Disposal Rate and Metabolism-associated Fatty Liver Disease in Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(26): 3252-3258. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||